GLP-1 Weight Loss: What Happens When You Stop?
The GLP-1 Cliff Edge: Why Maintaining Weight Loss May Require Lifelong Medication A startling statistic is emerging from recent studies: individuals who discontinue GLP-1 receptor agonists – drugs like Ozempic, Wegovy, and Mounjaro – face a substantially elevated risk of heart attack, stroke, and even death. This isn’t simply a return to pre-treatment health; it’s … Read more